Efficacy of Lansoprazole in Eradicating Helicobacter pylori : A Meta‐Analysis
Author:
Affiliation:
1. Dipartimento di Medicina Interna e Gastroenterologia, Policlinico Universitario Sant’ Orsola, Bologna, Italy
Publisher
Wiley
Subject
Infectious Diseases,Gastroenterology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1523-5378.1998.08029.x
Reference24 articles.
1. Helicobacter pyloriin peptic ulcer disease. NIH Consensus Development Panel onHelicobacter pyloriin Peptic Ulcer Disease. JAMA 1994;272:65–9.
2. Anti-Helicobacter pylori therapy: clearance, elimination, or eradication?
3. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection
4. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori
5. Activity of lansoprazole against Helicobacter pylori
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Innovative pH-dependent approach for electrochemical determination of a triple eradication therapy targeting H. Pylori infection in pharmaceutical formulation and human plasma sample: Modified electrode with Prussian blue analogue decorated multi-walled carbon nanotubes (PbA@MWCNT);Microchemical Journal;2022-10
2. Ecofriendly high‐performance thin‐layer chromatography‐densitometric method for determination of a new triple pharmaceutical combination targeting Helicobacter pylori eradication along with greenness profile assessment;SEPARATION SCIENCE PLUS;2022-05-12
3. Chromatographic estimation of a novel triple-therapy combination targeting Helicobacter pylori eradication in different matrices;Bioanalysis;2021-10
4. Treatment of Helicobacter pylori infection: a clinical practice update;Minerva Medica;2021-04
5. Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia;BMC Gastroenterology;2015-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3